All In MedTech

Device Trial Radar · NCT07928973

Clinical Application of a Novel Corneal Biomechanical Device in Refractive Surgery

A Study of the Clinical Applications of a Novel Corneal Biomechanical Device in Refractive Surgery

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Nov 4, 2026

Primary completion

Nov 1, 2027

Study completion Oct 31, 2028

Sponsor

Lead sponsor
Tianjin Eye HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 10, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study aims to evaluate the accuracy of corneal Young's modulus measurements (E\_Steady-State) obtained using a steady-state corneal biomechanical measurement device in patients scheduled to undergo refractive surgery and to explore their potential applications in assisting refractive surgical procedures.

Conditions

  • Corneal Biomechanics
  • Refractive Surgery

Interventions

  • Corneal steady-state biomechanical measurement device, Pentacam and Corvis STDevice

    Participants wear negative-pressure goggles, and a pressure test is performed to ensure an adequate seal. They then position their chin on the chinrest and fixate on a target while the operator aligns the imaging system with the cornea. The device applies controlled negative pressure and captures corneal deformation images using a Scheimpflug camera, with a coaxial imaging system assisting in alignment and monitoring eye movements. Following data acquisition, the software analyzes corneal biomechanical parameters and generates an assessment report.Perform surgery based on biomechanical parameters obtained from corneal steady-state biomechanical measurement device.

  • Pentacam and Corvis STDevice

    Morphological and biomechanical parameters were obtained by Pentacam and Corvis ST. Perform refractive surgery based on the surgeon's experience.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postoperative residual refractive errorTime frame: One year
  2. Visual acuityTime frame: One year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tianjin Eye Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.